Company Management, Scientific and Advisory Boards

Liver Cancer publications

Garin, E., Rolland, Y., Laffont, S., & Edeline, J. (2016). Clinical impact of 99mTc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with 90Y-loaded microspheres. European Journal of Nuclear Medicine and Molecular Imaging, 43(3), 559–575.
Palard, X., Edeline, J., Rolland, Y., Le Sourd, S., Pracht, M., Laffont, S., … Garin, E. (2018). Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma. European Journal of Nuclear Medicine and Molecular Imaging, 45(3), 392–401.
Raoul, J.-L., Boucher, E., Rolland, Y., & Garin, E. (2010). Treatment of hepatocellular carcinoma with intra-arterial injection of radionuclides. Nature Reviews Gastroenterology & Hepatology, 7(1), 41–49.
Le Dortz, L., De Guibert, S., Bayat, S., Devillers, A., Houot, R., Rolland, Y., … Garin, E. (2010). Diagnostic and prognostic impact of 18F-FDG PET/CT in follicular lymphoma. European Journal of Nuclear Medicine and Molecular Imaging, 37(12), 2307–2314.
Garin, E., Rolland, Y., Boucher, E., Ardisson, V., Laffont, S., Boudjema, K., … Raoul, J.-L. (2010). First experience of hepatic radioembolization using microspheres labelled with yttrium-90 (TheraSphere): practical aspects concerning its implementation. European Journal of Nuclear Medicine and Molecular Imaging, 37(3), 453–461.
Le Roux, P.-Y., Bouchet, F., Querellou, S., Vervueren, L., Lacoeuille, F., Turzo, A., … Couturier, O.-F. (2011). American consensus recommendations for gastric scintigraphy: curve fitting with only a few points remains an easy and accurate method to obtain reliable and reproducible gastric emptying estimates. Nuclear Medicine Communications, 32(1), 30–36.
Garin, E., Rolland, Y., Lenoir, L., Pracht, M., Mesbah, H., Porée, P., … Boucher, E. (2011). Utility of Quantitative 99m Tc-MAA SPECT/CT for 90 yttrium-Labelled Microsphere Treatment Planning: Calculating Vascularized Hepatic Volume and Dosimetric Approach. International Journal of Molecular Imaging, 2011, 1–8.
Garin, E., Lenoir, L., Rolland, Y., Laffont, S., Pracht, M., Mesbah, H., … Boucher, E. (2011). Effectiveness of quantitative MAA SPECT/CT for the definition of vascularized hepatic volume and dosimetric approach: phantom validation and clinical preliminary results in patients with complex hepatic vascularization treated with yttrium-90-labeled microspheres. Nuclear Medicine Communications, 32(12), 1245–1255.
Lenoir, L., Edeline, J., Rolland, Y., Pracht, M., Raoul, J.-L., Ardisson, V., … Garin, E. (2012). Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolization. European Journal of Nuclear Medicine and Molecular Imaging, 39(5), 872–880.
Edeline, J., Boucher, E., Rolland, Y., Vauléon, E., Pracht, M., Perrin, C., … Raoul, J.-L. (2012). Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma: mRECIST Impact in Sorafenib-Treated HCC. Cancer, 118(1), 147–156.
Garin, E., Lenoir, L., Rolland, Y., Edeline, J., Mesbah, H., Laffont, S., … Boucher, E. (2012). Dosimetry Based on 99mTc-Macroaggregated Albumin SPECT/CT Accurately Predicts Tumor Response and Survival in Hepatocellular Carcinoma Patients Treated with 90Y-Loaded Glass Microspheres: Preliminary Results. Journal of Nuclear Medicine, 53(2), 255–263.
Masserot-Lureau, C., Adoui, N., Degos, F., de Bazelaire, C., Soulier, J., Chevret, S., … Leblanc, T. (2012). Incidence of liver abnormalities in Fanconi anemia patients. American Journal of Hematology, 87(5), 547–549.
Boudjema, K., Sulpice, L., Garnier, S., Bretagne, J.-F., Gandon, Y., & Rohou, T. (2013). A Simple System to Predict Perihilar Cholangiocarcinoma Resectability. Journal of Gastrointestinal Surgery, 17(7), 1247–1256.
Fosse, P., Girault, S., Hoareau, J., Testard, A., Couturier, O., & Morel, O. (2013). Unusual Uptake of 18FDG by a Hepatic Adenoma: Clinical Nuclear Medicine, 38(2), 135–136.
Carlier, T., Eugène, T., Bodet-Milin, C., Garin, E., Ansquer, C., Rousseau, C., … Kraeber-Bodéré, F. (2013). Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT. EJNMMI Research, 3(1), 11.
Edeline, J., Du, F. L., Rayar, M., Rolland, Y., Beuzit, L., Boudjema, K., … Boucher, E. (2015). Glass Microspheres 90Y Selective Internal Radiation Therapy and Chemotherapy as First-Line Treatment of Intrahepatic Cholangiocarcinoma: Clinical Nuclear Medicine, 40(11), 851–855.
Edeline, J., Crouzet, L., Campillo-Gimenez, B., Rolland, Y., Pracht, M., Guillygomarc’h, A., … Garin, E. (2016). Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis. European Journal of Nuclear Medicine and Molecular Imaging, 43(4), 635–643.
Beuzit, L., Edeline, J., Brun, V., Ronot, M., Guillygomarc’h, A., Boudjema, K., … Rolland, Y. (2016). Comparison of Choi criteria and Response Evaluation Criteria in Solid Tumors (RECIST) for intrahepatic cholangiocarcinoma treated with glass-microspheres Yttrium-90 selective internal radiation therapy (SIRT). European Journal of Radiology, 85(8), 1445–1452.
Garin, E., Edeline, J., & Rolland, Y. (2016). High Impact of Preferential Flow on 99mTc-MAA and 90Y-Loaded Microsphere Uptake Correlation. Journal of Nuclear Medicine, 57(11), 1829–1830.
Garin, E., Rolland, Y., Pracht, M., Le Sourd, S., Laffont, S., Mesbah, H., … Edeline, J. (2017). High impact of macroaggregated albumin-based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with 90 Y-loaded glass microsphere radioembolization. Liver International, 37(1), 101–110.
Vilgrain, V., Pereira, H., Assenat, E., Guiu, B., Ilonca, A. D., Pageaux, G.-P., … Marthey, L. (2017). Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial. The Lancet Oncology, 18(12), 1624–1636.
Manceau, V., Palard, X., Rolland, Y., Pracht, M., Le Sourd, S., Laffont, S., … Garin, E. (2018). A MAA-based dosimetric study in patients with intrahepatic cholangiocarcinoma treated with a combination of chemotherapy and 90Y-loaded glass microsphere selective internal radiation therapy. European Journal of Nuclear Medicine and Molecular Imaging, 45(10), 1731–1741.
Simoncini, C., Jurczuk, K., Reska, D., Esneault, S., Nunes, J.-C., Bellanger, J.-J., … Kretowski, M. (2018). Towards a patient-specific hepatic arterial modeling for microspheres distribution optimization in SIRT protocol. Medical & Biological Engineering & Computing, 56(3), 515–529.
Garin, E., Rolland, Y., Campillo-Gimenez, B., & Edeline, J. (2018). Negative phase 3 study of 90 Y microspheres versus sorafenib in HCC. The Lancet Oncology, 19(2), e70.
Winter, K. S., Hofmann, F. O., Thierfelder, K. M., Holch, J. W., Hesse, N., Baumann, A. B., … D’Anastasi, M. (2018). Towards volumetric thresholds in RECIST 1.1: Therapeutic response assessment in hepatic metastases. European Radiology, 28(11), 4839–4848.
Bourien, H., Palard, X., Rolland, Y., Le Du, F., Beuzit, L., Uguen, T., … Edeline, J. (2019). Yttrium-90 glass microspheres radioembolization (RE) for biliary tract cancer: a large single-center experience. European Journal of Nuclear Medicine and Molecular Imaging, 46(3), 669–676.
Delaunay, K., Edeline, J., Rolland, Y., Lepareur, N., Laffont, S., Palard, X., … Garin, E. (2019). Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with 188Re-SSS Lipiodol radioembolization. European Journal of Nuclear Medicine and Molecular Imaging, 46(7), 1506–1517.
Edeline, J., Touchefeu, Y., Guiu, B., Farge, O., Tougeron, D., Baumgaertner, I., … Garin, E. (2020). Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial. JAMA Oncology, 6(1), 51.
Garin, E., Rolland, Y., & Edeline, J. (2019). 90Y-Loaded Microsphere SIRT of HCC Patients With Portal Vein Thrombosis: High Clinical Impact of 99mTc-MAA SPECT/CT-Based Dosimetry. Seminars in Nuclear Medicine, 49(3), 218–226.